You are here:Home-Chemical Inhibitors & Agonists-Metabolic Enzyme/Protease-Cathepsin-Z-Tyr-Ala-CHN2
Z-Tyr-Ala-CHN2

Chemical Structure : Z-Tyr-Ala-CHN2

CAS No.: 114515-99-0

Z-Tyr-Ala-CHN2

Catalog No.: PC-20410Not For Human Use, Lab Use Only.

Z-Tyr-Ala-CHN2 is a potent cathepsin L inhibitor with EC50 of <50 nM, has broad-spectrum coronavirus antiviral activity.

Packing Price Stock Quantity
100 mg Get quote
200 mg Get quote
500 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

Z-Tyr-Ala-CHN2 is a potent cathepsin L inhibitor with EC50 of <50 nM, has broad-spectrum coronavirus antiviral activity.
Z-Tyr-Ala-CHN2 showed activity against SARS-CoV-1 and HCoV-229E, with EC50 of 0.050 and 0.069 µM, respectively.
Z-Tyr-Ala-CHN2 potently inhibit infection in SARS-CoV-2 both A549-hACE2 and HeLa-hACE2 cells with EC50 of 0.046 and 0.006 uM, with no effect in Caco-2 cells.
Z-Tyr-Ala-CHN2 acts on the endosomal entry pathway in pseudotyped SARS-CoV-2 neutralization assay in VeroE6 cells.

Physicochemical Properties

M.Wt 410.43
Formula C21H22N4O5
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

benzyl ((S)-1-(((S)-4-diazo-3-oxobutan-2-yl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl)carbamate

References

1. Jordi Doijen, et al. Microorganisms. 2023 Mar 10;11(3):717.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: